SHL Telemedicine (NASDAQ:SHLT) Trading Up 11.2% – Should You Buy?

SHL Telemedicine Ltd. (NASDAQ:SHLT) traded up 11.2% on Monday . The company traded as high as $3.19 and last traded at $3.17. 6,267 shares traded hands during trading, an increase of 76% from the average session volume of 3,568 shares. The stock had previously closed at $2.85.

SHL Telemedicine Trading Up 11.2 %

The company has a fifty day moving average price of $3.01 and a 200 day moving average price of $4.02. The company has a quick ratio of 1.98, a current ratio of 2.17 and a debt-to-equity ratio of 0.19.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SHL Telemedicine stock. Y.D. More Investments Ltd acquired a new stake in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 2,219,610 shares of the company’s stock, valued at approximately $11,351,000. SHL Telemedicine makes up about 1.2% of Y.D. More Investments Ltd’s portfolio, making the stock its 22nd biggest position. Y.D. More Investments Ltd owned approximately 15.12% of SHL Telemedicine at the end of the most recent quarter. 20.11% of the stock is owned by institutional investors and hedge funds.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.